Press Releases
SCOR's first quarter of 2014 results.
- FR
- EN
1764
-
-
Press ReleasesAll the proposed resolutions were adopted by SCOR’s shareholders by a very large majority, including payment of a dividend of EUR 1.30 per share for the 2013 financial year.
-
Press ReleasesSCOR Global Life's embedded value results of 2013.
-
documentMay 6, 2014 — 00:00
SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%
-
documentApril 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
-
documentApril 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
-
documentApril 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
-
documentApril 28, 2014 — 00:00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
-
documentApril 28, 2014 — 00:00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
-
Press Releases
Availability of the documents relating to the 2014 combined general shareholders' meeting.
-
Press ReleasesFounded in 1921 by a cooperative of French university professors, PUF is a publishing house specialising in the publication of books, journals, university manuals, essays and monographs in the field of humanities and
-
documentApril 10, 2014 — 00:00
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
